Pfizer - 46 Year Stock Price History | PFE

Historical daily share price chart and data for Pfizer since 1972 adjusted for splits and dividends. Open, high, low, close (OHLC) data as well as percentage changes for multiple date ranges. Display 20, 50 and 200 day moving averages and export charts as images to use in articles and blogs. The latest closing price for Pfizer as of October 17, 2018 is 44.57.
Pfizer Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2018 37.6373 35.4557 45.4700 33.0236 44.5700 26.47%
2017 32.5882 30.8984 36.1951 29.1662 35.2416 15.88%
2016 30.2127 28.8147 34.2965 26.0178 30.4115 4.46%
2015 29.9422 27.3389 32.0866 27.1905 29.1124 7.10%
2014 26.0213 25.6699 28.0021 23.9639 27.1818 5.30%
2013 24.0720 21.1287 27.1362 21.0797 25.8131 26.22%
2012 18.6037 17.2437 21.0391 16.6129 20.4513 20.41%
2011 15.0349 13.3179 17.1338 12.9471 16.9847 28.77%
2010 12.3842 13.6835 14.4569 10.4280 13.1899 0.31%
2009 11.1595 12.5297 13.6256 8.1721 13.1486 8.26%
2008 12.7991 14.7232 15.4752 9.9099 12.1456 -16.85%
2007 15.8650 16.1428 17.3656 14.3312 14.6076 -8.15%
2006 15.5014 14.0753 17.3251 13.5134 15.9033 15.22%
2005 14.8912 15.1897 16.8375 12.1930 13.8030 -10.62%
2004 18.7187 19.9996 21.8561 13.9492 15.4424 -22.31%
2003 17.7921 17.4080 20.1644 15.8459 19.8759 17.76%
2002 19.0877 21.7096 22.9338 14.1981 16.8780 -22.16%
2001 22.5663 24.8458 24.8458 19.2588 21.6824 -12.49%
2000 22.2826 17.0198 26.2824 16.0589 24.7758 43.06%
1999 20.4850 21.7966 26.5373 16.8500 17.3188 -21.50%
1998 17.9601 13.2566 22.2555 12.9501 22.0614 68.94%
1997 9.8060 7.0811 13.6279 7.0811 13.0587 81.93%
1996 6.2849 5.2945 7.8266 5.1670 7.1780 33.96%
1995 4.0711 3.1624 5.6348 3.1050 5.3583 66.70%
1994 2.6786 2.7473 3.2714 2.1828 3.2144 15.31%
1993 2.5608 2.8479 2.9792 2.1390 2.7877 -2.28%
1992 2.9215 3.2406 3.3081 2.5785 2.8526 -11.97%
1991 2.2677 1.5114 3.3081 1.4078 3.2406 112.75%
1990 1.2705 1.2914 1.5374 1.0288 1.5232 20.49%
1989 1.1255 1.0139 1.3597 0.9596 1.2642 24.16%
1988 0.9273 0.8217 1.0335 0.8217 1.0182 29.21%
1987 1.1007 1.0389 1.2818 0.7035 0.7880 -22.90%
1986 1.0097 0.8378 1.2190 0.7875 1.0221 20.49%
1985 0.7747 0.6764 0.9341 0.6387 0.8483 19.83%
1984 0.5979 0.6054 0.7079 0.5027 0.7079 18.18%
1983 0.6457 0.5676 0.7498 0.5676 0.5990 3.79%
1982 0.5063 0.4398 0.6681 0.4210 0.5771 29.37%
1981 0.4123 0.4461 0.4587 0.3414 0.4461 0.00%
1980 0.3480 0.3142 0.4461 0.2734 0.4461 35.26%
1979 0.2794 0.2775 0.3414 0.2451 0.3298 18.85%
1978 0.2661 0.2293 0.3215 0.2136 0.2775 21.02%
1977 0.2239 0.2409 0.2409 0.1969 0.2293 -6.45%
1976 0.2366 0.2378 0.2618 0.2136 0.2451 4.92%
1975 0.2503 0.2691 0.3058 0.2011 0.2336 -14.56%
1974 0.2778 0.3623 0.3696 0.1811 0.2734 -24.54%
1973 0.3676 0.3654 0.4388 0.3257 0.3623 0.86%
Sector Industry Market Cap Revenue
Medical Large Cap Pharmaceutical $265.319B $52.546B
Pfizer Inc. is a research-based, global pharmaceutical company that discovers, develops, manufactures, and markets medicines for humans and animals. The Company's diversified global healthcare portfolio includes human and animal biologic and small molecule medicines and vaccines, as well as nutritional products and consumer healthcare products. Pfizer's Animal Health business unit discovers, develops and sells products for the prevention and treatment of diseases in livestock and companion animals. It sells its products to wholesalers, distributors, retailers, hospitals, clinics, government agencies, pharmacies, individual provider offices, veterinarians, livestock producers, and grocery and convenience stores. Pfizer Inc. is headquartered in New York.
Stock Name Country Market Cap PE Ratio
Johnson & Johnson (JNJ) United States $374.158B 17.54
Novartis AG (NVS) Switzerland $197.633B 16.95
Merck (MRK) United States $193.640B 17.10
AbbVie (ABBV) United States $139.722B 13.65
Eli Lilly (LLY) United States $121.994B 22.58
Sanofi (SNY) France $112.061B 14.18
Novo Nordisk (NVO) Denmark $106.293B 16.99
AstraZeneca (AZN) United Kingdom $99.517B 10.94
GlaxoSmithKline (GSK) United Kingdom $98.553B 13.16
Bristol-Myers Squibb (BMY) United States $96.274B 17.43